Can Vitamin B12 Deficiency Be a Sign of Cancer? What the Evidence Actually Says

The Short Answer (Before You Panic)

Let me say the thing you came here to hear, right up front. Can vitamin B12 deficiency be a sign of cancer? Rarely. In the vast majority of cases, low B12 has nothing to do with a tumor. It’s diet, it’s absorption, it’s a medication you’ve been taking for years. Cancer is way down the list.

But (and here’s where it gets interesting) the relationship isn’t zero. It exists. It’s just more tangled than the scary headlines suggest.

I’ve spent a good chunk of my career looking at B12 lab results, and I’ll be honest about what I see. Most people who walk in with a low B12 are vegans who stopped eating fortified foods, or 70-year-olds whose stomachs no longer produce enough acid, or diabetics on metformin. Not cancer patients.

Here’s the part that surprises almost everyone. It’s not just low B12 that carries a cancer association. High B12 does too. That’s not a typo. Some of the strongest signals in the research actually point to elevated B12 levels being a red flag for certain cancers, particularly liver and blood cancers. We’ll get to that.

So the honest answer is layered. Low B12 can, in specific situations, be tied to cancer, mostly gastrointestinal cancers that mess with absorption or an autoimmune condition called pernicious anemia that raises stomach cancer risk. But the deficiency itself is almost never the cancer’s calling card.

My goal with this article is simple. I want to give you the evidence, not fear. By the end you’ll understand exactly when low B12 is worth investigating, when it’s boring and benign, and why your doctor might care more about the cause than the number itself.

Take a breath. Then let’s look at what B12 deficiency actually is.

The Short Answer (Before You Panic)

What B12 Deficiency Actually Is

The role B12 plays in the body

Think of B12 as a specialized wrench your cells reach for during two critical jobs. The first is DNA synthesis. Every time a cell divides, it needs B12 (working alongside folate) to build new genetic material correctly. The second is keeping your nervous system insulated, since B12 helps maintain the myelin sheath that wraps around your nerves like protective tape around wiring.

Then there’s red blood cell production. Without enough B12, your bone marrow starts churning out oversized, malformed red cells that can’t do their job properly. That’s why classic deficiency shows up as a specific type of anemia called megaloblastic anemia.

So when B12 runs low, you get a predictable mess. Fatigue. Tingling in the hands and feet. Brain fog. A sore, beefy-looking tongue in some cases. Balance problems if it drags on long enough. The nerve damage can become permanent, which is exactly why nobody should sit on a real deficiency.

How deficiency is measured

Here’s where a lot of people get misled, including some clinicians. The standard test is serum B12, the amount floating around in your blood. It’s cheap and everywhere. It’s also unreliable on its own.

Why? Because serum B12 measures total B12, but a big fraction of that is bound to a protein called haptocorrin and isn’t actually available to your cells. You can have a “normal” serum number and still be functionally deficient at the tissue level.

That’s why smarter workups add two functional markers. Methylmalonic acid (MMA) and homocysteine. When B12 is genuinely low inside your cells, both of these metabolites pile up because B12 is needed to clear them. Elevated MMA is the more specific of the two. If your serum B12 is borderline but your MMA is high, you’re deficient. Full stop.

What normal vs low looks like on labs

Most labs flag anything under 200 pg/mL as deficient. Above 300 pg/mL is generally considered fine. The trouble sits in that gray zone between 200 and 300, where symptoms and metabolic markers matter more than the raw number.

Deficiency is common, more common than people assume. Estimates suggest around 6% of adults under 60 in the US and UK are deficient, climbing to roughly 20% in older adults when you use functional markers. Older folks get hit hardest because stomach acid and intrinsic factor production both decline with age.

What B12 Deficiency Actually Is

The Real Common Causes of Low B12 (Cancer Is Far Down the List)

Let me give you perspective by ranking what actually drives low B12. Because when patients spiral into worst-case thinking, this list is the reality check.

Diet and vegan/vegetarian patterns

B12 comes almost exclusively from animal foods. Meat, fish, eggs, dairy. Plants don’t make it. So if you eat a strict plant-based diet without supplements or fortified foods, you’re on a slow countdown to deficiency. Your liver stores a few years’ worth, which is why it can take a while to show up, but it will.

This is the single most preventable cause. If you’re vegan and not supplementing, that’s almost certainly your answer, not a tumor.

Pernicious anemia and autoimmune causes

Pernicious anemia is an autoimmune condition where your immune system attacks the cells in your stomach that make intrinsic factor, the protein B12 needs to hitch a ride and get absorbed in the small intestine. No intrinsic factor, no absorption, no matter how much B12 you eat.

It’s the classic cause of severe deficiency and it deserves attention for a specific reason. Pernicious anemia itself carries a raised risk of stomach cancer, which is the cleanest link between B12 deficiency and cancer we have. I’ll unpack that mechanism in a moment because it’s the crux of this whole question.

Medications like metformin and PPIs

This one flies under the radar constantly. Metformin, the most prescribed diabetes drug on the planet, interferes with B12 absorption in the gut. The numbers aren’t trivial. A trial published in Diabetes Care (2010) found that long-term metformin use reduced B12 levels significantly, with deficiency rates rising the longer people took it and the higher the dose.

Proton pump inhibitors do damage too. Drugs like omeprazole suppress stomach acid, and you need that acid to free B12 from food. Lam et al. reported in JAMA (2013) that using PPIs for two or more years was associated with a 65% higher risk of B12 deficiency in a large case-control analysis of over 25,000 patients. H2 blockers showed a smaller but real effect.

If you’re on either of these, that’s a far more likely culprit than anything sinister.

Gut and absorption disorders

Your ileum, the tail end of the small intestine, is where B12 gets absorbed. Anything that damages it or removes it causes trouble. Crohn’s disease. Celiac disease. Bowel resection surgery. Bariatric surgery, which is increasingly common. Bacterial overgrowth in the small intestine can also gobble up B12 before you do.

Aging deserves its own line here. As stomach acid drops with age, so does your ability to liberate B12 from food, a condition called food-bound B12 malabsorption. This is why deficiency spikes in the elderly even when their diet looks fine on paper.

So there’s the honest hierarchy. Diet, medications, autoimmune pernicious anemia, gut disorders, aging. Cancer isn’t even in the top five for most people. But it’s not absent either, and now we get to the part you actually clicked for.

The Real Common Causes of Low B12 (Cancer Is Far Down the List)

So Where Does Cancer Come Into It?

Alright. Let’s talk about the real connections, because there are a few and they’re worth understanding precisely rather than vaguely worrying about.

Stomach cancer and pernicious anemia

This is the strongest and best-documented link, so I’ll spend the most time here. Remember pernicious anemia, that autoimmune attack on stomach cells? The same chronic inflammation that destroys intrinsic-factor-producing cells (a condition called atrophic gastritis) also creates fertile ground for cancer over time.

The data are consistent. A meta-analysis in Gastroenterology (2013) pooled cohort studies and found that people with pernicious anemia had roughly a 6 to 7-fold increased relative risk of gastric cancer, plus a striking increase in gastric carcinoid tumors. Murphy and colleagues, in a large US cohort published in 2015, confirmed the elevated risk persisted for years after diagnosis.

Here’s how I explain it to patients. The autoimmune process slowly wears down the stomach lining. That damaged, inflamed, acid-depleted environment is exactly the kind of place where abnormal cells get a chance to accumulate mutations. B12 deficiency is the visible symptom. The gastric damage underneath is the actual cancer risk. The deficiency is a flag pointing at the stomach, not the tumor itself.

So if you’re diagnosed with pernicious anemia, this is why a good clinician may recommend an endoscopy to check the stomach lining. Not to frighten you. To look upstream.

Cancers that impair absorption

The second connection is mechanical. Any cancer sitting in the parts of your digestive tract responsible for B12 handling can wreck absorption.

Gastric cancer can destroy the stomach cells that make intrinsic factor. Cancers of the ileum, or tumors that require surgical removal of that segment, take out the exact site where B12 gets absorbed. Pancreatic cancer can interfere too, since pancreatic enzymes help release B12 from its carrier proteins earlier in digestion.

In these cases the low B12 is a downstream consequence of a tumor physically disrupting the plumbing. It’s real, but it’s almost never the first or only sign. There’d typically be weight loss, pain, bleeding, or changes in bowel habits alongside it. Isolated low B12 with zero other symptoms pointing to a rare GI cancer is not the usual story.

Bone marrow and hematologic cancers

Now here’s the twist I promised. Blood cancers and myeloproliferative disorders more often push B12 in the opposite direction. Up, not down.

Leukemias, especially chronic myeloid leukemia, and other myeloproliferative conditions can dramatically raise serum B12. The reason is that these cancers overproduce white blood cells, and those cells release large amounts of the B12-binding proteins (transcobalamins and haptocorrin) into the blood. More binding proteins, more measured B12, even though the functional availability may be off.

This is why I keep hammering the point that high B12 can be the more alarming lab finding. Arendt et al. published a striking analysis in the Journal of the National Cancer Institute (2013) tracking over 300,000 patients. People with the highest B12 levels had a substantially increased risk of being diagnosed with cancer within the following year, with the strongest signals for liver, blood, and other solid cancers. The one-year cancer risk in the highest B12 group was several times that of people with normal levels.

Let that sink in. If you’re worried about cancer and your B12 comes back sky-high with no supplement to explain it, that deserves a look. A high number can be more meaningful than a low one.

So how do these threads come together in a way that actually helps you decide what to do? That’s where we’re headed next.

So Where Does Cancer Come Into It?

The Plot Twist: High B12 Is the Bigger Cancer Red Flag

Here’s the part almost nobody expects. When we talk about whether can vitamin B12 deficiency be a sign of cancer, the honest answer flips the whole question on its head. It’s usually not the low number that worries an oncologist. It’s the high one.

Yeah. I was surprised too the first time I looked at the data closely.

What elevated B12 (hypercobalaminemia) signals

Your B12 doesn’t just float around freely. Most of it rides on carrier proteins called transcobalamins, and some of those proteins get produced in higher amounts when certain tissues go haywire. Liver cells make them. So do some white blood cells. When those cells proliferate abnormally (say, in a tumor or in liver disease), your measured B12 can climb even though your tissues aren’t getting more of the vitamin.

Think of it like a warehouse fire that trips every smoke alarm in the building. The alarm reading is high, but the “signal” is telling you something is burning, not that you have too much of a good thing.

The Danish cohort findings

The strongest evidence here comes from Denmark. Arendt and colleagues, publishing in the Journal of the National Cancer Institute in 2013, tracked more than 333,000 people who’d had a B12 test ordered. The finding that got everyone’s attention: patients with elevated serum B12 had a substantially higher risk of being diagnosed with cancer within the following year, and the risk climbed with the level.

For people whose B12 sat above 800 pmol/L, cancer risk within a year was roughly 3 to 6 times higher than for those with normal levels. That’s not a rounding error. That’s a real signal.

Liver and blood cancers

Which cancers? Mostly liver, and blood cancers like leukemia and myeloproliferative disorders. Solid tumors of the pancreas and colon showed up too. A follow-up analysis by the same Danish group reinforced the pattern for hematological and liver-related malignancies specifically.

Now, let me be clear about what this means for you. This is about unexplained high B12, in someone who isn’t taking supplements. If you’re popping a 1,000 mcg B12 tablet every morning, your serum level will read high, and that tells us nothing about cancer. That’s just the supplement showing up in the blood.

The reader who typed “can vitamin b12 deficiency be a sign of cancer” came here worried about a low number. And low B12 does occasionally matter (I’ll get to exactly when). But the counterintuitive truth is that an unexplained high reading, not a low one, is the pattern that reliably makes doctors order more tests.

When Low B12 Should Actually Prompt a Cancer Workup

Okay. Back to the low side, because that’s the real question. Most low B12 has a boring explanation: not enough in the diet, metformin, acid-reducing meds, age-related absorption decline. But there’s a subset where I’d want a closer look, and the pattern matters more than the number.

Red flag symptoms to watch

Here’s what stops me. Low B12 by itself? Common, usually benign. Low B12 alongside any of these? Different conversation.

• Unexplained weight loss (the kind you didn’t try for)
• Blood in the stool, or black tarry stools suggesting a GI bleed
• Anemia that stays anemic despite proper supplementation
• Persistent stomach pain, early fullness, or trouble swallowing
• Iron deficiency and B12 deficiency showing up together

That last combination is one I take seriously. When both iron and B12 run low at the same time, it points to a problem in the gut, either poor absorption across a damaged stomach lining or slow bleeding somewhere in the tract. Both deserve a real answer.

Age and risk factors

Age changes the math. A 28-year-old vegan with low B12 needs a diet fix and a supplement. A 68-year-old with new low B12, weight loss, and anemia needs an endoscopy. Same lab value, wildly different next step.

The strongest tumor link runs through the stomach. Chronic atrophic gastritis and pernicious anemia damage the cells that make intrinsic factor (the protein B12 needs to get absorbed), and that same damaged stomach lining carries a raised risk of gastric cancer over time. A 2015 systematic review in Gastroenterology pooled cohorts on pernicious anemia and found roughly a 6- to 7-fold increase in gastric cancer risk compared with the general population. Not enormous in absolute terms, but real enough that guidelines suggest surveillance.

What tests a doctor might order

So what does the workup look like? If the pattern is concerning, I’d expect some combination of:

• Intrinsic factor antibodies and parietal cell antibodies to confirm pernicious anemia
• Methylmalonic acid (MMA) to prove the deficiency is real at the tissue level
• Iron studies and a full blood count to characterize the anemia
• Upper endoscopy if there’s atrophic gastritis, GI bleeding, weight loss, or unexplained iron loss
• Fecal occult blood testing to check for hidden bleeding

The goal isn’t to scare you into a scope. It’s to separate routine deficiency (the overwhelming majority) from the small slice where the low B12 is a downstream clue about the stomach. The number opens the conversation. The symptoms and age decide how far it goes.

Does Fixing B12 Deficiency Affect Cancer Risk?

This is where I have to slow down, because the supplement data gets messy and I don’t want to oversell either direction.

Supplementation and the mixed data

Let me be straight about where the data is strong and where it isn’t. Correcting a genuine B12 deficiency improves anemia and neurological symptoms. That part is settled. Whether taking B vitamins changes your cancer risk is a much murkier picture.

The big randomized trials mostly looked at B vitamins together (folic acid, B6, B12) for heart disease, with cancer tracked as a secondary outcome. NORVIT, the Norwegian Vitamin Trial published in the New England Journal of Medicine in 2006, gave folic acid plus B12 to heart-attack survivors and found no cardiovascular benefit, and a hint (not conclusive) of increased cancer over follow-up.

The B-PROOF trial out of the Netherlands, reported around 2014, gave folic acid and B12 to older adults for bone health. A long-term follow-up raised a colorectal cancer question, though the numbers were small and the finding uncertain.

The folate-B12 interaction

Here’s the thing that ties it together. Most of the worrying signals come from combining B12 with folic acid, not B12 alone. Folate feeds cell division. There’s a plausible worry that in someone with an early, undetected precancerous lesion, high-dose folate might accelerate what’s already there. B12 gets swept into that concern because the two are usually studied as a package.

Should you supplement or not

The clearest cancer signal came from high-dose B6 and B12, not folate, and not in women. The VITAL cohort (Vitamins and Lifestyle), published in the Journal of Clinical Oncology in 2017, found that men taking high-dose B6 and B12 from individual supplements over years had a notably higher lung cancer risk, and the effect was strongest in male smokers. Long-term high-dose B12 use in that group was linked to roughly a doubling of lung cancer risk.

That’s a specific, narrow finding. Men. Smokers. High-dose individual supplements taken for years. It is not a reason for someone with a real deficiency to avoid treatment.

So what’s the best dosage? For correcting a deficiency, standard replacement is 1,000 mcg orally daily (or intramuscular injections if absorption is the problem), stepping down to a maintenance dose once levels normalize. That’s a world away from someone with normal B12 megadosing “for energy” indefinitely. My take is simple: treat a documented deficiency, don’t megadose a normal level, and if you smoke, skip the high-dose B-vitamin stacks entirely.

What I'd Do If My B12 Came Back Low

Let me make this practical, because “go see someone” isn’t very useful on its own. Here’s the exact sequence I’d follow if my own B12 came back low.

First, confirm it’s real. Serum B12 is a flawed test. If my number landed in the gray zone (200 to 300 pg/mL) or I had symptoms with a “normal” reading, I’d ask for MMA and homocysteine. Elevated MMA is the tiebreaker. It tells you the deficiency has actually reached your cells, not just your bloodstream.

Second, hunt for the cause. Low B12 is a symptom, not a diagnosis. I’d run through the checklist: Am I on metformin? A daily proton pump inhibitor? Do I eat animal products? Any gut surgery or Crohn’s history? Most people find their answer right here.

Third, check for pernicious anemia if the diet and meds don’t explain it. Intrinsic factor antibodies are cheap and revealing. Positive result changes everything, because it means lifelong monitoring and, per the gastric cancer link, likely some surveillance down the road.

Fourth, watch for the red flags. Weight loss, GI bleeding, stubborn anemia, iron and B12 dropping together. Any of those and I’d push for endoscopy rather than just swallowing a supplement and moving on.

Now the realistic part. How fast does treatment work? Blood markers rebound within days to a couple weeks. Anemia clears over one to two months. Nerve symptoms are the slow ones, three to six months, and if you let a deficiency run for years, some nerve damage may not fully come back. That timeline is exactly why “just supplement it” without finding the cause is a mistake. You might mask the number while missing what caused it.

I’ll be honest about my bias here. I’m usually the skeptic in the room, and I think the cancer fear around low B12 is overblown for most people. But I also think “your B12 is a little low, take this and don’t worry” is lazy medicine. The number is a starting point. Where it came from is the whole game.

The Takeaway

If you came here scared that a low B12 result means cancer, exhale. For the vast majority of people, it doesn’t. Your low number is far more likely explained by what you eat, what medications you take, or how well your aging stomach absorbs nutrients than by anything sinister.

But I won’t hand you false reassurance either. The pattern matters. Low B12 with weight loss, bleeding, or anemia that won’t budge is worth chasing down. Pernicious anemia is worth confirming, because it carries a modest gastric cancer risk that justifies keeping an eye on things. And an unexplained high B12, oddly enough, is the reading I’d want investigated fastest.

My advice boils down to three moves. Confirm the deficiency is real with MMA. Find out what caused it instead of just swallowing a pill. And if red flags show up, push for the endoscopy rather than waiting. Do those three things and you’ve handled the actual risk, minus the panic that sent you searching in the first place.

Frequently Asked Questions

MD, PhD

Dr. Dimitar Marinov

Medical Reviewer • Chief Assistant Professor, Medical University of Varna

Dr. Marinov is a licensed physician and scientist specializing in nutrition and dietetics with years of experience in clinical and preventive medicine. He references every statement with high-quality research.

LinkedIn Instagram Google Scholar ResearchGate Website